Chronic respiratory failure is a progressive condition in which the respiratory system fails to maintain adequate gas exchange, leading to persistent hypoxemia, hypercapnia, or both. It often develops secondary to chronic lung diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, cystic fibrosis, neuromuscular disorders, or chest wall deformities. Patients may experience exertional or resting shortness of breath, fatigue, morning headaches, sleep disturbances, and diminished exercise tolerance. Unlike acute respiratory failure, chronic forms develop gradually, allowing partial physiological adaptation, but they still significantly impair quality of life and increase susceptibility to infections and cardiovascular complications. Early recognition through clinical assessment, arterial blood gas analysis, and pulmonary function testing is crucial to guide management and prevent disease progression.
Management of chronic respiratory failure requires a comprehensive, individualized approach. Oxygen therapy is prescribed to correct hypoxemia, while non-invasive ventilation supports breathing in patients with hypercapnia or muscle weakness. Pharmacologic therapies targeting underlying lung disease, along with pulmonary rehabilitation, help optimize lung function and endurance. Regular monitoring of arterial blood gases and periodic reassessment of pulmonary mechanics allow timely adjustment of therapy. Nutritional support, vaccination, and infection prevention strategies are essential adjuncts. Multidisciplinary care involving pulmonologists, respiratory therapists, and nutritionists ensures holistic support. Patient education regarding symptom recognition, adherence to therapy, and lifestyle modifications empowers individuals to actively manage their condition. With proactive interventions, patients with chronic respiratory failure can achieve improved functional capacity, reduced hospitalizations, and enhanced overall quality of life.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation